title: Omacetaxine: the FDA decision.
authors.affiliation: Leukemia Service, Division of Hematologic Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
authors.forename: Ellin
authors.initials: E
authors.lastname: Berman
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D017277:Drug Approval; D055808:Drug Discovery; D006248:Harringtonines / Q000627:therapeutic use*; D000077863:Homoharringtonine; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D006248:Harringtonines; D000077863:Homoharringtonine